GENILGen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim SirketiGENIL info
$2.62info0.28%24h
Global rank8946
Market cap$786.81M
Change 7d-5.65%
YTD Performance90.59%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (GENIL) Stock Overview

    Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration and licensing agreement with Sulfateq BV for the development and commercialization of the original molecule SUL-238 as a unique treatment for Alzheimer's disease and other neurodegenerative diseases. The company was incorporated in 1997 and is headquartered in Çankaya, Turkey.

    GENIL Stock Information

    Symbol
    GENIL
    Address
    Mustafa Kemal Mahallesi 2119.Sk. No:3Çankaya, 06520Turkey
    Founded
    -
    Trading hours
    -
    Website
    https://www.genilac.com.tr
    Country
    🇹🇷 Turkey
    Phone Number
    90 312 219 62 19

    Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (GENIL) Price Chart

    -
    Value:-

    Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.62
    N/A
    Market Cap
    $786.81M
    N/A
    Shares Outstanding
    300.00M
    N/A
    Employees
    619.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org